Cambrex Corporation (Cambrex) is a life sciences company, which provides products and services, which accelerate and improve the development and commercialization of new and generic therapeutics. The Company's business is consisted of the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. Its products include active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The Company supplies its products and services globally to generic pharmaceutical companies. The Company's owns 51% stake in Zenara Pharma (Zenara), which focuses on the formulation of final dosage form products. The Company's products are sold through a combination of direct sales and independent agents.